Stocks and Investing
Stocks and Investing
Tue, July 2, 2024
[ Tue, Jul 02nd 2024
] - WOPRAI
[ Tue, Jul 02nd 2024
] - WOPRAI
[ Tue, Jul 02nd 2024
] - WOPRAI
[ Tue, Jul 02nd 2024
] - WOPRAI
[ Tue, Jul 02nd 2024
] - WOPRAI
[ Tue, Jul 02nd 2024
] - WOPRAI
[ Tue, Jul 02nd 2024
] - WOPRAI
[ Tue, Jul 02nd 2024
] - WOPRAI
[ Tue, Jul 02nd 2024
] - WOPRAI
[ Tue, Jul 02nd 2024
] - WOPRAI
[ Tue, Jul 02nd 2024
] - WOPRAI
[ Tue, Jul 02nd 2024
] - WOPRAI
[ Tue, Jul 02nd 2024
] - WOPRAI
[ Tue, Jul 02nd 2024
] - WOPRAI
[ Tue, Jul 02nd 2024
] - WOPRAI
[ Tue, Jul 02nd 2024
] - WOPRAI
[ Tue, Jul 02nd 2024
] - WOPRAI
[ Tue, Jul 02nd 2024
] - WOPRAI
[ Tue, Jul 02nd 2024
] - WOPRAI
[ Tue, Jul 02nd 2024
] - WOPRAI
[ Tue, Jul 02nd 2024
] - WOPRAI
[ Tue, Jul 02nd 2024
] - WOPRAI
[ Tue, Jul 02nd 2024
] - WOPRAI
[ Tue, Jul 02nd 2024
] - WOPRAI
[ Tue, Jul 02nd 2024
] - WOPRAI
[ Tue, Jul 02nd 2024
] - WOPRAI
Mon, July 1, 2024
[ Mon, Jul 01st 2024
] - WOPRAI
Raghuram Selvaraju Reiterated (URGN) at Strong Buy and Held Target at $60 on, Jul 1st, 2024
Raghuram Selvaraju of HC Wainwright & Co., Reiterated "UroGen Pharma Ltd." (URGN) at Strong Buy and Held Target at $60 on, Jul 1st, 2024.
Raghuram has made no other calls on URGN in the last 4 months.
There are 2 other peers that have a rating on URGN. Out of the 2 peers that are also analyzing URGN, 0 agree with Raghuram's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Raghuram
- Leland Gershell of "Oppenheimer" Maintained at Buy with Increased Target to $40 on, Friday, June 14th, 2024
- Matthew Kaplan of "Ladenburg Thalmann" Maintained at Strong Buy with Increased Target to $54 on, Friday, June 14th, 2024
Contributing Sources